{"filing":{"accession_number":"0001437749-26-023932","cik":"0002030617","ticker":"PMI","company_name":"Picard Medical, Inc.","form":"8-K","filing_date":"2026-07-21","report_date":null,"primary_document":"pmi20260720_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2030617/000143774926023932/pmi20260720_8k.htm"},"events":[{"id":19061,"run_id":17154,"accession_number":"0001437749-26-023932","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a classic Item 5.07 disclosure reporting the results of Picard Medical's Annual Meeting of Stockholders held on July 17, 2026. The filing presents voting results for six matters: election of four directors, advisory approval of named executive officer compensation, frequency of future advisory votes on compensation, approval of a reverse stock split amendment (1-for-15 to 1-for-50 ratio), designation of Class B common stock with 20 votes per share, and ratification of MaloneBailey LLP as independent auditor. All matters were approved. The reverse stock split authorization and Class B voting structure are material governance and capital structure changes affecting shareholder rights and equity value.","company_name":"Picard Medical, Inc.","ticker":"PMI","filing_date":"2026-07-21","form":"8-K","submitted_at":null,"items":[{"id":18053,"accession_number":"0001437749-26-023932","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure reporting the results of Picard Medical's Annual Meeting of Stockholders held on July 17, 2026. The filing presents voting results for six matters: election of four directors, advisory approval of named executive officer compensation, frequency of future advisory votes on compensation, approval of a reverse stock split amendment (1-for-15 to 1-for-50 ratio), designation of Class B common stock with 20 votes per share, and ratification of MaloneBailey LLP as independent auditor. All matters were approved. The reverse stock split authorization and Class B voting structure are material governance and capital structure changes affecting shareholder rights and equity value.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-21T18:02:36.611238+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":18053,"accession_number":"0001437749-26-023932","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure reporting the results of Picard Medical's Annual Meeting of Stockholders held on July 17, 2026. The filing presents voting results for six matters: election of four directors, advisory approval of named executive officer compensation, frequency of future advisory votes on compensation, approval of a reverse stock split amendment (1-for-15 to 1-for-50 ratio), designation of Class B common stock with 20 votes per share, and ratification of MaloneBailey LLP as independent auditor. All matters were approved. The reverse stock split authorization and Class B voting structure are material governance and capital structure changes affecting shareholder rights and equity value.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-21T18:02:36.611238+00:00","company_name":"Picard Medical, Inc.","ticker":"PMI","filing_date":"2026-07-21"}]}